InsightRX Secures Growth Financing from CIBC Innovation Banking to Advance Personalized Drug Dosing with AI.
InsightRX is at the forefront of transforming drug dosing from a conventional one-size-fits-all approach to a more personalized treatment paradigm.
Company Name: InsightRX
Location: San Francisco, CA
Sector: Healthcare Software
Funding Details: Received Growth financing from CIBC Innovation Banking. The amount was not disclosed.
Purpose of Investment: To expand operations and development efforts.
Leadership: CEO Sirj Goswami
Product: InsightRX leverages quantitative pharmacology and AI to tailor dosing for complex treatments. The platform employs patient-specific data and models to optimize dosing strategies, significantly impacting antibiotics, chemotherapeutics, and immunosuppressants' administration. Additionally, it aids data scientists in clinical trial data analysis, contributing to more effective trial designs and dosing strategies.
About Company: InsightRX is at the forefront of transforming drug dosing from a conventional one-size-fits-all approach to a more personalized treatment paradigm. By incorporating the unique characteristics of individual patients, InsightRX's platform enhances treatment effectiveness, streamlines new drug introductions, and directly benefits patients with tailored care.
